Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.

about

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.

Item

http://www.wikidata.org/entity/Q48101262

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Decision analysis of allogenei ...... nal Prognostic Scoring System.

@en

Decision analysis of allogenei ...... nal Prognostic Scoring System.

@nl

type

Item

label

Decision analysis of allogenei ...... nal Prognostic Scoring System.

@en

Decision analysis of allogenei ...... nal Prognostic Scoring System.

@nl

prefLabel

Decision analysis of allogenei ...... nal Prognostic Scoring System.

@en

Decision analysis of allogenei ...... nal Prognostic Scoring System.

@nl

P1476

Decision analysis of allogenei ...... nal Prognostic Scoring System.

@en

P2093

A Bacigalupo

http://www.w3.org/2001/XMLSchema#string

A Molteni

http://www.w3.org/2001/XMLSchema#string

A P Iori

http://www.w3.org/2001/XMLSchema#string

A Rambaldi

http://www.w3.org/2001/XMLSchema#string

B Allione

http://www.w3.org/2001/XMLSchema#string

C H Jackson

http://www.w3.org/2001/XMLSchema#string

C Pascutto

http://www.w3.org/2001/XMLSchema#string

E Oldani

http://www.w3.org/2001/XMLSchema#string

E P Alessandrino

http://www.w3.org/2001/XMLSchema#string

E Todisco

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome

International scoring system for evaluating prognosis in myelodysplastic syndromes

Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data.

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

Revised international prognostic scoring system for myelodysplastic syndromes.

Estimation in Markov models from aggregate data.

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.

P2888

leu.2017.88

P304

2449-2457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2017.88

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28321120

http://www.w3.org/2001/XMLSchema#string

P932

6086331

http://www.w3.org/2001/XMLSchema#string